
Austrianova Singapore Pte. Ltd.
"Austrianova utilizes a novel and proprietary technology for the encapsulation of living cells. Cell-in-a-Box® protects the encapsulated cells from rejection by the immune system, allows cells to be easily transported, stored and implanted at specific sites in patients. Bac-in-a-Box® is a similar protective device adapted for encapsulation of probiotic bacteria where it has human food and animal feed applications due to its ability to extend storage under lyophilized conditions and to protect encapsulated bacteria against destruction by stomach acid. Austrianova also offers GMP4Cells that includes competitively priced Master Cell Bank and Working Cell Bank production as well as “Fill and Finish” services for cell therapy products."
Extra Info
Title: Home - Austrianova
URL Source: http://austrianova.com/
Published Time: 2020-05-30T20:14:56+00:00
Markdown Content:
CELL ENCAPSULATION
Body Armour for Living Cells: protects, shields and extends the life of living cells
What’s new?
Austrianova has successfully completed its ISO 9001:2015 QMS recertification audit on 21 February 2025.
Micro-encapsulation of living cells for immuno-protection and localization in patients
Encapsulation of probiotic bacteria and yeast for stomach acid protection and ambient storage
HOW IT WORKS
Our Services
To find out more about our unique award winning protective cell encapsulation technology and our cell biology expertise, click a panel on the right.
Cell-in-a-Box® technology, developed by Austrianova, is a means to protect, isolate, store and transport human and animal cells.
The Cell-in-a-Box® technology builds a porous capsule round the cells, allowing free diffusion of nutrients in, and waste products out, and also allowing any biological molecules synthesized by the cells to escape.
Bac-in-a-Box® technology, developed by Austrianova, is a means to protect, isolate, store and transport living bacteria and yeast.
Bac-in-a-Box® technology builds a porous capsule round the bacteria or yeast, allowing free diffusion of nutrients in, and waste products out, and also allowing the bacteria and yeast to grow in the capsules.
They can then be released from the capsule.
Austrianova offers a standardised cell therapy that can be used for all patients without requiring use of the patient’s own cells. This is called allogenic therapy. It can be used for treating diseases as diverse as Graft versus Host disease, various types of cancer and for infectious diseases.
Austrianova offers a complete cell R&D service from sourcing cells, to designing appropriate plasmids, to generating and characterising clones and finally testing those cell clones in various in vitro or in vivo assays. We have an extensive network of trusted partners with whom we can cooperate if the project requires it.
Austrianova is a B2B company that offers a full GMP service for living eukaryotic human and animal cells. We can prepare cell banks and process cell lines in a US-FDA compliant manner. We can grow up adherent or non-adherent qualified cells (supplied with the necessary documentation as to sterility and adventitious micro-organisms)